FDA drug safety

The U.S. pharmaceutical industry faces another high-stakes recall as multiple batches of alprazolam, commonly known by the brand name Xanax, have been pulled from pharmacy shelves. The recall, initiated by several manufacturers and the FDA, centers on concerns over potential contamination and inconsistencies in dosage strength. While Xanax remains one of the most prescribed anti-anxiety…